BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14575846)

  • 1. Technical aspects of daily online positioning of the prostate for three-dimensional conformal radiotherapy using an electronic portal imaging device.
    Herman MG; Pisansky TM; Kruse JJ; Prisciandaro JI; Davis BJ; King BF
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):1131-40. PubMed ID: 14575846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate position relative to pelvic bony anatomy based on intraprostatic gold markers and electronic portal imaging.
    Schallenkamp JM; Herman MG; Kruse JJ; Pisansky TM
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):800-11. PubMed ID: 16199313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First clinical release of an online, adaptive, aperture-based image-guided radiotherapy strategy in intensity-modulated radiotherapy to correct for inter- and intrafractional rotations of the prostate.
    Deutschmann H; Kametriser G; Steininger P; Scherer P; Schöller H; Gaisberger C; Mooslechner M; Mitterlechner B; Weichenberger H; Fastner G; Wurstbauer K; Jeschke S; Forstner R; Sedlmayer F
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1624-32. PubMed ID: 22209149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daily electronic portal imaging of implanted gold seed fiducials in patients undergoing radiotherapy after radical prostatectomy.
    Schiffner DC; Gottschalk AR; Lometti M; Aubin M; Pouliot J; Speight J; Hsu IC; Shinohara K; Roach M
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):610-9. PubMed ID: 17236978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tracking target position variability using intraprostatic fiducial markers and electronic portal imaging in prostate cancer radiotherapy.
    Munoz F; Fiandra C; Franco P; Guarneri A; Ciammella P; De Stefanis P; Rondi N; Moretto F; Badellino S; Iftode C; Ragona R; Ricardi U
    Radiol Med; 2012 Sep; 117(6):1057-70. PubMed ID: 22327924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Image-guided radiotherapy in near real time with intensity-modulated radiotherapy megavoltage treatment beam imaging.
    Mao W; Hsu A; Riaz N; Lee L; Wiersma R; Luxton G; King C; Xing L; Solberg T
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):603-10. PubMed ID: 19735886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portal imaging protocol for radical dose-escalated radiotherapy treatment of prostate cancer.
    Mubata CD; Bidmead AM; Ellingham LM; Thompson V; Dearnaley DP
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):221-31. PubMed ID: 9422580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of the No Action Level (NAL) protocol to correct for prostate motion based on electronic portal imaging of implanted markers.
    de Boer HC; van Os MJ; Jansen PP; Heijmen BJ
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):969-83. PubMed ID: 15752876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On-line aSi portal imaging of implanted fiducial markers for the reduction of interfraction error during conformal radiotherapy of prostate carcinoma.
    Chung PW; Haycocks T; Brown T; Cambridge Z; Kelly V; Alasti H; Jaffray DA; Catton CN
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):329-34. PubMed ID: 15337572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daily organ tracking in intensity-modulated radiotherapy of prostate cancer using an electronic portal imaging device with a dose saving acquisition mode.
    Vetterli D; Thalmann S; Behrensmeier F; Kemmerling L; Born EJ; Mini R; Greiner RH; Aebersold DM
    Radiother Oncol; 2006 Apr; 79(1):101-8. PubMed ID: 16621076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasound-based stereotactic guidance in prostate cancer--quantification of organ motion and set-up errors in external beam radiation therapy.
    Lattanzi J; McNeeley S; Donnelly S; Palacio E; Hanlon A; Schultheiss TE; Hanks GE
    Comput Aided Surg; 2000; 5(4):289-95. PubMed ID: 11029161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daily electronic portal imaging for morbidly obese men undergoing radiotherapy for localized prostate cancer.
    Millender LE; Aubin M; Pouliot J; Shinohara K; Roach M
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):6-10. PubMed ID: 15093893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fiducial markers implanted during prostate brachytherapy for guiding conformal external beam radiation therapy.
    Welsh JS; Berta C; Borzillary S; Sam C; Shickell D; Nobile L; Greenberg M; Weiss S; Detorie N
    Technol Cancer Res Treat; 2004 Aug; 3(4):359-64. PubMed ID: 15270586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate movement during simulation resulting from retrograde urethrogram compared with "natural" prostate movement.
    Liu YM; Ling S; Langen KM; Shinohara K; Weinberg V; Pouliot J; Roach M
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):470-5. PubMed ID: 15380581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Method comparison of ultrasound and kilovoltage x-ray fiducial marker imaging for prostate radiotherapy targeting.
    Fuller CD; Thomas CR; Schwartz S; Golden N; Ting J; Wong A; Erdogmus D; Scarbrough TJ
    Phys Med Biol; 2006 Oct; 51(19):4981-93. PubMed ID: 16985282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a semi-automatic alignment tool for accelerated localization of the prostate.
    Hua C; Lovelock DM; Mageras GS; Katz MS; Mechalakos J; Lief EP; Hollister T; Lutz WR; Zelefsky MJ; Ling CC
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):811-24. PubMed ID: 12573769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraprostatic fiducials for localization of the prostate gland: monitoring intermarker distances during radiation therapy to test for marker stability.
    Kupelian PA; Willoughby TR; Meeks SL; Forbes A; Wagner T; Maach M; Langen KM
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1291-6. PubMed ID: 16029784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective clinical evaluation of an electronic portal imaging device.
    Michalski JM; Graham MV; Bosch WR; Wong J; Gerber RL; Cheng A; Tinger A; Valicenti RK
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):943-51. PubMed ID: 8598374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of residual error for online cone-beam CT-guided treatment of prostate cancer patients.
    LĂ©tourneau D; Martinez AA; Lockman D; Yan D; Vargas C; Ivaldi G; Wong J
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1239-46. PubMed ID: 15913917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daily online localization using implanted fiducial markers and its impact on planning target volume for carcinoma prostate.
    Khosa R; Nangia S; Chufal KS; Ghosh D; Kaul R; Sharma L
    J Cancer Res Ther; 2010; 6(2):172-8. PubMed ID: 20622364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.